Treatment of diseases of the superficial veins, such as varicose veins, and related complications, phlebothrombosis, thrombophlebitis, and superficial periflebitis. Postoperative varicose phlebitis, complications after surgical removal of the saphenous vein of the leg. Injuries and bruises, infiltrates and localized edema, subcutaneous hematomas. Injuries and sprains of muscle-tendon and capsule-connected structures.
Geparin gel 600 IU/g Pharmacological properties
sodium heparin – a direct anticoagulant – blocks the biosynthesis of thrombin, inhibits the formation of fibrin from fibrinogen, reduces platelet aggregation and inhibits the activity of hyaluronidase. when applied topically, heparin-Darnitsa gel has an antithrombotic, anti-inflammatory and anti-edema effect. the drug does not exhibit a local irritating effect.
When applied to the skin, a small amount of sodium heparin enters the systemic circulation, which is excreted mainly by the kidneys.
Geparin gel 600 IU/g Indications
Treatment of superficial vein diseases such as varicose veins and related complications, phlebothrombosis, thrombophlebitis, superficial periphlebitis. postoperative varicose phlebitis, complications after surgical removal of the saphenous vein of the lower extremity. injuries and bruises, infiltrates and localized edema, subcutaneous hematomas. injuries and sprains of muscle-tendon and capsule-ligamentous structures.
Geparin gel 600 IU/g Application
The drug heparin-Darnitsa is applied topically, 3-10 cm of the gel is applied with light rubbing movements on the skin of the affected area 1-3 times a day. the dose of the drug depends on the area of the affected area. the duration of treatment is determined by the doctor individually, taking into account the severity of the course of the disease.
Individual hypersensitivity to heparin or any of the components of the drug, trophic ulcers of the lower extremities, bleeding and / or infected wounds, hemorrhagic diathesis, purpura, thrombocytopenia, hemophilia. bleeding tendency.
Dermatological disorders: skin edema, rash, itching, redness, swelling, burning sensation, hemorrhage, sometimes – the appearance of small pustules, vesicles or blisters, which quickly disappear after the drug is discontinued.
From the immune system: hypersensitivity reactions, including urticaria, angioedema.
When applied to large areas of the skin, systemic adverse reactions may develop.